144 related articles for article (PubMed ID: 31929901)
1. Association of Estimated Insulin Resistance with N-Terminal B-Type Natriuretic Peptide Concentration in Men with Metabolic Syndrome.
Krzesiński P; Piechota W; Piotrowicz K; Gielerak G; Woźniak-Kosek A
Cardiol Res Pract; 2019; 2019():8571795. PubMed ID: 31929901
[TBL] [Abstract][Full Text] [Related]
2. Insulin Resistance and N-Terminal Pro-B-Type Natriuretic Peptide Among Healthy Adults.
Echouffo-Tcheugui JB; Zhang S; McEvoy JW; Juraschek SP; Fang M; Ndumele CE; Christenson RH; Selvin E
JAMA Cardiol; 2023 Oct; 8(10):989-995. PubMed ID: 37672260
[TBL] [Abstract][Full Text] [Related]
3. N-terminal pro-B-type natriuretic peptide is inversely associated with metabolic syndrome in hypertensive patients.
Chang HR; Hsieh JC; Hsu BG; Wang LY; Yu-Chih Chen M; Wang JH
Am J Med Sci; 2014 Sep; 348(3):210-4. PubMed ID: 24736765
[TBL] [Abstract][Full Text] [Related]
4. Inverse association of N-terminal pro-B-type natriuretic peptide with metabolic syndrome in patients with congestive heart failure.
Chang HR; Hsieh JC; Hsu BG; Wang LY; Chen MY; Wang JH
PLoS One; 2013; 8(11):e79096. PubMed ID: 24265747
[TBL] [Abstract][Full Text] [Related]
5. Insulin resistance is associated with increased concentrations of NT-proBNP in rheumatoid arthritis: IL-6 as a potential mediator.
Bradham WS; Ormseth MJ; Oeser A; Solus JF; Gebretsadik T; Shintani A; Stein CM
Inflammation; 2014 Jun; 37(3):801-8. PubMed ID: 24402421
[TBL] [Abstract][Full Text] [Related]
6. Brain natriuretic peptide and insulin resistance in older adults.
Kim F; Biggs ML; Kizer JR; Brutsaert EF; de Filippi C; Newman AB; Kronmal RA; Tracy RP; Gottdiener JS; Djoussé L; de Boer IH; Psaty BM; Siscovick DS; Mukamal KJ
Diabet Med; 2017 Feb; 34(2):235-238. PubMed ID: 27101535
[TBL] [Abstract][Full Text] [Related]
7. Levels of N-terminal pro brain natriuretic peptide are enhanced in people with the uncomplicated metabolic syndrome: a case-cohort analysis of the population-based Casale Monferrato study.
Bruno G; Barutta F; Landi A; Pinach S; Caropreso P; Mengozzi G; Baldassarre S; Fragapani S; Civera S; Cavallo Perin P; Gruden G
Diabetes Metab Res Rev; 2015 May; 31(4):360-7. PubMed ID: 25370350
[TBL] [Abstract][Full Text] [Related]
8. Fatty Liver Is Associated with Low N-Terminal Pro-B-Type Natriuretic Peptide in a Healthy Population.
Choi HI; Lee MY; Oh BK; Lee SJ; Kang JG; Lee SH; Lee JY; Kim BJ; Kim BS; Kang JH; Sung KC
J Clin Med; 2021 Apr; 10(7):. PubMed ID: 33915723
[TBL] [Abstract][Full Text] [Related]
9. Sex-specific associations of obesity and N-terminal pro-B-type natriuretic peptide levels in the general population.
Suthahar N; Meijers WC; Ho JE; Gansevoort RT; Voors AA; van der Meer P; Bakker SJL; Heymans S; van Empel V; Schroen B; van der Harst P; van Veldhuisen DJ; de Boer RA
Eur J Heart Fail; 2018 Aug; 20(8):1205-1214. PubMed ID: 29855124
[TBL] [Abstract][Full Text] [Related]
10. Statin treatment is associated with a negative correlation between NT-proBNP and insulin resistance in patients without history of heart failure.
Wang JS; Lee CL; Lee WJ; Lee IT; Lin SY; Lee WL; Liang KW; Sheu WH
Clin Chim Acta; 2016 Aug; 459():84-88. PubMed ID: 27221204
[TBL] [Abstract][Full Text] [Related]
11. [N-terminal pro-brain natriuretic peptide (NT-proBNP) and ischemia modified albumin (IMA) in exercise induced ischemia in patients with stable coronary artery disease].
Piechota WN; Wierzbowski R; Piechota WT; Bejm J; Gielerak G
Pol Arch Med Wewn; 2006 Jul; 116(1):640-7. PubMed ID: 17340970
[TBL] [Abstract][Full Text] [Related]
12. Early cardiac abnormalities and serum N-terminal pro B-type natriuretic peptide levels in obese children.
Battal F; Ermis B; Aktop Z; Can M; Demirel F
J Pediatr Endocrinol Metab; 2011; 24(9-10):723-6. PubMed ID: 22145463
[TBL] [Abstract][Full Text] [Related]
13. Sex and Race Differences in N-Terminal Pro-B-type Natriuretic Peptide Concentration and Absolute Risk of Heart Failure in the Community.
Myhre PL; Claggett B; Yu B; Skali H; Solomon SD; Røsjø H; Omland T; Wiggins KL; Psaty BM; Floyd JS; Selvin E; Ballantyne CM; Shah AM
JAMA Cardiol; 2022 Jun; 7(6):623-631. PubMed ID: 35476049
[TBL] [Abstract][Full Text] [Related]
14. N-terminal pro-brain natriuretic peptide (NT-proBNP) in healthy blood donors and in patients from general practitioners with and without a diagnosis of cardiac disease.
Hess G; Runkel S; Zdunek D; Hitzler WE
Clin Lab; 2005; 51(3-4):167-72. PubMed ID: 15819172
[TBL] [Abstract][Full Text] [Related]
15. Relation of NT-probnp levels and cardiovascular disease risk factors in lean women with polycystic ovary syndrome.
Karadağ C; Yoldemir T
J Obstet Gynaecol; 2019 Nov; 39(8):1154-1159. PubMed ID: 31215274
[TBL] [Abstract][Full Text] [Related]
16. Correlation between B type natriuretic peptide and metabolic risk factors.
Zhu WH; Chen LY; Dai HL; Chen JH; Chen Y; Fang LZ
Arch Med Sci; 2016 Apr; 12(2):334-40. PubMed ID: 27186177
[TBL] [Abstract][Full Text] [Related]
17. The prognostic value of the plasma N-terminal pro-brain natriuretic peptide level on all-cause death and major cardiovascular events in a community-based population.
Zhu Q; Xiao W; Bai Y; Ye P; Luo L; Gao P; Wu H; Bai J
Clin Interv Aging; 2016; 11():245-53. PubMed ID: 27013868
[TBL] [Abstract][Full Text] [Related]
18. The influence of body composition on the N-terminal pro-B-type natriuretic peptide level and its prognostic performance in patients with acute coronary syndrome: a cohort study.
Huang FY; Wang H; Huang BT; Liu W; Peng Y; Zhang C; Xia TL; Wang PJ; Zuo ZL; Heng Y; Liu RS; Pu XB; Gui YY; Chen SJ; Zhu Y; Chen M
Cardiovasc Diabetol; 2016 Apr; 15():58. PubMed ID: 27048159
[TBL] [Abstract][Full Text] [Related]
19. Echocardiographic assessment and N-terminal pro-brain natriuretic peptide in hypertensives with metabolic syndrome.
Krzesiński P; Uziebło-Życzkowska B; Gielerak G; Stańczyk A; Piotrowicz K; Piechota W; Smurzyński P; Skrobowski A
Adv Clin Exp Med; 2017; 26(2):295-301. PubMed ID: 28791849
[TBL] [Abstract][Full Text] [Related]
20. Interaction of Body Mass Index on the Association Between N-Terminal-Pro-b-Type Natriuretic Peptide and Morbidity and Mortality in Patients With Acute Heart Failure: Findings From ASCEND-HF (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure).
Bhatt AS; Cooper LB; Ambrosy AP; Clare RM; Coles A; Joyce E; Krishnamoorthy A; Butler J; Felker GM; Ezekowitz JA; Armstrong PW; Hernandez AF; O'Connor CM; Mentz RJ
J Am Heart Assoc; 2018 Feb; 7(3):. PubMed ID: 29431103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
